2-[3-[4-[4-(benzenesulfonyl)-2,6-dimethylphenyl]pyrazol-1-yl]phenoxy]-9-(4-fluoro-2-pyridinyl)carbazole
C40H29FN4O3S — CID 153413835
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[3-[4-[4-(benzenesulfonyl)-2,6-dimethylphenyl]pyrazol-1-yl]phenoxy]-9-(4-fluoro-2-pyridinyl)carbazole
2-[3-[4-[4-(benzenesulfonyl)-2,6-dimethylphenyl]pyrazol-1-yl]phenoxy]-9-(4-fluoro-2-pyridinyl)carbazole (PubChem CID 153413835) has the molecular formula C40H29FN4O3S and a molecular weight of 664.76 g/mol. Its IUPAC name is 2-[3-[4-[4-(benzenesulfonyl)-2,6-dimethylphenyl]pyrazol-1-yl]phenoxy]-9-(4-fluoro-2-pyridinyl)carbazole.
Molecular Properties
| Compound Name | 2-[3-[4-[4-(benzenesulfonyl)-2,6-dimethylphenyl]pyrazol-1-yl]phenoxy]-9-(4-fluoro-2-pyridinyl)carbazole |
|---|---|
| PubChem CID | 153413835 |
| Molecular Formula | C40H29FN4O3S |
| Molecular Weight | 664.76 g/mol |
| Exact Mass | 664.19 |
| IUPAC Name | 2-[3-[4-[4-(benzenesulfonyl)-2,6-dimethylphenyl]pyrazol-1-yl]phenoxy]-9-(4-fluoro-2-pyridinyl)carbazole |
| SMILES | Cc1cc(S(=O)(=O)c2ccccc2)cc(C)c1-c1cnn(-c2cccc(Oc3ccc4c5ccccc5n(-c5cc(F)ccn5)c4c3)c2)c1 |
| InChI | InChI=1S/C40H29FN4O3S/c1-26-19-34(49(46,47)33-11-4-3-5-12-33)20-27(2)40(26)28-24-43-44(25-28)30-9-8-10-31(22-30)48-32-15-16-36-35-13-6-7-14-37(35)45(38(36)23-32)39-21-29(41)17-18-42-39/h3-25H,1-2H3 |
| InChIKey | IXFKWSXNEGFNCF-UHFFFAOYSA-N |
| XLogP | 9.41 |
| TPSA | 79.01 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 49 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 664.76 |
| LogP ≤ 5 | 9.41 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 153413835 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.